Literature DB >> 13680537

Dye-induced nephropathy.

Samuel N Heyman1, Seymour Rosen.   

Abstract

The expanding use of imaging and interventional studies with iodinated radiologic contrast agents underscores the potential risk for dye nephropathy. Currently, dye-induced nephropathy is one of the leading causes of iatrogenic acute kidney failure, accounting for about 10% of renal failure in intensive care units. In this review, the pathophysiology of radiocontrast nephropathy is discussed, with a special emphasis on the importance of medullary hypoxic damage. The risk factors and clinical course of dye nephropathy, as well as its prevention or potential therapeutic interventions, are discussed in this perspective.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13680537     DOI: 10.1016/s0270-9295(03)00092-5

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  1 in total

1.  Acetazolamide for prevention of contrast-induced nephropathy: a new use for an old drug.

Authors:  Farahnak Assadi
Journal:  Pediatr Cardiol       Date:  2006 Mar-Apr       Impact factor: 1.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.